• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:王丽,陈国清.阿昔洛韦片中杂质的色谱-质谱结构分析[J].中国现代应用药学,2024,41(1):62-70.
WANG Li,CHEN Guoqing.Structural Analysis of Impurities in Aciclovir Tablets by HPLC-MS/MS[J].Chin J Mod Appl Pharm(中国现代应用药学),2024,41(1):62-70.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 819次   下载 496 本文二维码信息
码上扫一扫!
分享到: 微信 更多
阿昔洛韦片中杂质的色谱-质谱结构分析
王丽, 陈国清
无锡市药品安全检验检测中心,江苏 无锡 214028
摘要:
目的 建立高效液相色谱-四级杆-静电场轨道阱高分辨质谱(HPLC-Q-Exactive Orbitrap-MS)联用法对阿昔洛韦片及其强制降解试验样品中的杂质进行结构分析。方法 采用Waters Xbridge BEH Shield RP18(4.6 mm×250 mm,5 μm)色谱柱,以10 mmol·L–1甲酸铵溶液(含0.15%甲酸)为流动相A,以10 mmol·L–1甲酸铵溶液(含0.15%甲酸)-乙腈(50∶50)为流动相B,进行梯度洗脱,检测波长为254 nm,对阿昔洛韦片及其强制降解试验样品中的杂质进行分离,再采用Q-Exactive Orbitrap-MS测定各杂质一级精确分子量及二级碎片离子,并进行结构鉴定。结果 阿昔洛韦及其杂质均分离良好,检测并鉴定出阿昔洛韦片及其强制降解试验样品中8个含量>0.1%的主要杂质,其中4个为欧洲药典10.0规定的已知杂质,而其他杂质均未见报道。结论 建立的液质联用技术能有效鉴定阿昔洛韦片的杂质,能够为其生产工艺的优化和质量控制提供参考。
关键词:  阿昔洛韦  四极杆-静电场轨道阱高分辨质谱  杂质  降解产物  结构鉴定
DOI:10.13748/j.cnki.issn1007-7693.20221878
分类号:R917.101
基金项目:国家药品监督管理局化学药品杂质谱研究重点实验室开放课题项目( NMPA-KLIPCD-2020-02)
Structural Analysis of Impurities in Aciclovir Tablets by HPLC-MS/MS
WANG Li, CHEN Guoqing
Wuxi Institute for Drug Control, Wuxi 214028, China
Abstract:
OBJECTIVE To analysis the structures of the impurities in aciclovir tablets and the compulsory degradation samples by high performance liquid chromatography coupled with hybrid quadrupole orbitrap mass spectrometry technology (HPLC-Q-Exactive Orbitrap-MS). METHODS The HPLC separation was carried out on a Waters Xbridge BEH Shield RP18 (4.6 mm×250 mm, 5 μm) by the gradient elution with a mobile phase consisting of 10 mmol·L–1 ammonium formate solution (0.15% formic acid)(A) and 10 mmol·L–1 ammonium formate solution(0.15% formic acid)-acetonitrile(50∶50)(B), and the detection wavelength was 254 nm. The Q-Exactive Orbitrap-MS was used to determine the precise first-order molecular weight and second-order fragment ions of these impurities, and the structures were identified. RESULTS Aciclovir and its impurities were well separated, and 8 major impurities with content>0.1% were detected and identified in aciclovir tablets and the compulsory degradation samples. Among them, 4 were the impurities listed in the European Pharmacopeia 10.0, and the others were unknown impurities identified for the first time. CONCLUSION The LC-MS/MS method can effectively identify the impurities in aciclovir tablets, which is significant for the production process optimization and quality control.
Key words:  aciclovir  Q-Exactive Orbitrap-MS  impurities  degradation products  structural identification
扫一扫关注本刊微信